S. Rao

发表

New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story

M. Barrett, J. Mottram, P. Mäser, 2020, Tropical medicine and infectious disease.

Drug Discovery for Kinetoplastid Diseases: Future Directions.

G. Dranoff, M. Barrett, J. Mottram, 2018, ACS infectious diseases.

Discovery of Novel Quinoline-Based Proteasome Inhibitors for Human African Trypanosomiasis (HAT)

F. Supek, M. Barrett, H. Cheung, 2022, Journal of medicinal chemistry.

Toward More Drug Like Inhibitors of Trypanosome Alternative Oxidase.

S. Ward, Srinivasa P. S. Rao, Ryan A. West, 2018, ACS infectious diseases.

Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agents.

Paul W Smith, S. Peukert, N. Ma, 2015, European journal of medicinal chemistry.

Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agents.

Shi Hua Ang, Paul W Smith, K. Kuhen, 2013, ACS medicinal chemistry letters.

African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase

S. Ward, J. Atack, Srinivasa P. S. Rao, 2017, European journal of medicinal chemistry.

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis

Se Yeon Kim, R. Wintjens, J. Cechetto, 2013, Nature Medicine.

Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability.

K. Pethe, T. Dick, M. Gengenbacher, 2010, Microbiology.

The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis

Thomas Dick, T. Dick, S. Alonso, 2008, Proceedings of the National Academy of Sciences.